Low-dose imatinib therapy leads to rapid induction of major molecular responses with achievement of molecular remission in FIP1L1 -PDGFRA associated hypereosinophilic syndrome


Jovanovic, J., Score, J., Waghorn, K., Reiter, A., Gottardi, E., Saglio, G., Apperley, J., Martinelli, G., Preudhomme, C., Hehlmann, R., Grimwade, D. and Cross, N.C.P. (2006) Low-dose imatinib therapy leads to rapid induction of major molecular responses with achievement of molecular remission in FIP1L1 -PDGFRA associated hypereosinophilic syndrome British Journal of Haematology, 133, (s1), p.13. (doi:10.1111/j.1365-2141.2006.06027.x).

Download

Full text not available from this repository.

Item Type: Article
Digital Object Identifier (DOI): doi:10.1111/j.1365-2141.2006.06027.x
ISSNs: 0007-1048 (print)
Keywords: publishing, england, imatinib, hypereosinophilic syndrome, germany, france, london, syndrome, italy, therapy, time
Subjects:
ePrint ID: 59897
Date :
Date Event
April 2006Published
Date Deposited: 17 Nov 2008
Last Modified: 16 Apr 2017 17:33
Further Information:Google Scholar
URI: http://eprints.soton.ac.uk/id/eprint/59897

Actions (login required)

View Item View Item